Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QIDX | 11.48 | 0.03 | +0.27% |
| Indexperts Quality Earnings Focused ETF (QIDX) | |||
| REMC | 22.74 | -0.02 | -0.08% |
| Columbia Research Enhanced Mid Cap ETF (REMC) | |||
| NAZ | 10.11 | -0.06 | -0.59% |
| Nuveen Arizona Quality Municipal Income Fund | |||
| XME | 87.37 | -1.82 | -2.04% |
| State Street SPDR S&P Metals & Mining ETF (XME) | |||
| CRAK | 54.40 | -1.83 | -3.25% |
| VanEck Oil Refiners ETF (CRAK) | |||
A.I.dvisor tells us that ATTO and BTCT have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ATTO and BTCT's prices will move in lockstep.
| Ticker / NAME | Correlation To ATTO | 1D Price Change % | ||
|---|---|---|---|---|
| ATTO | 100% | +4.51% | ||
| BTCT - ATTO | 20% Poorly correlated | N/A | ||
| UTI - ATTO | 20% Poorly correlated | +0.82% | ||
| GPN - ATTO | 12% Poorly correlated | +0.35% | ||
| EFX - ATTO | 10% Poorly correlated | -0.35% | ||
| EVLV - ATTO | 9% Poorly correlated | +1.03% | ||
More | ||||
a provider of customer relationship management business process outsourcing services and solutions
Industry Biotechnology